BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matos AI, Carreira B, Peres C, Moura LI, Conniot J, Fourniols T, Scomparin A, Martínez-barriocanal Á, Arango D, Conde JP, Préat V, Satchi-fainaro R, Florindo HF. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 2019;307:108-38. [DOI: 10.1016/j.jconrel.2019.06.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Fei Y, Ma Y, Zhang H, Li H, Feng G, Fang J. Nanotechnology for research and treatment of the intestine. J Nanobiotechnology 2022;20:430. [PMID: 36175955 DOI: 10.1186/s12951-022-01517-3] [Reference Citation Analysis]
2 Younis NK, Roumieh R, Bassil EP, Ghoubaira JA, Kobeissy F, Eid AH. Nanoparticles: attractive tools to treat colorectal cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.08.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fatfat Z, Fatfat M, Gali-Muhtasib H. Micelles as potential drug delivery systems for colorectal cancer treatment. World J Gastroenterol 2022; 28(25): 2867-2880 [DOI: 10.3748/wjg.v28.i25.2867] [Reference Citation Analysis]
4 Gholami M, Darroudi M, Hekmat A, Khazaei M. Five-FU@CuS/NH2 -UiO-66 as a drug delivery system for 5-fluorouracil to colorectal cancer cells. J Biochem Mol Toxicol 2022;:e23145. [PMID: 35702888 DOI: 10.1002/jbt.23145] [Reference Citation Analysis]
5 Zumaya ALV, Rimpelová S, Štějdířová M, Ulbrich P, Vilčáková J, Hassouna F. Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma. Int J Mol Sci 2022;23:1200. [PMID: 35163122 DOI: 10.3390/ijms23031200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol 2021;12:735965. [PMID: 34987385 DOI: 10.3389/fphar.2021.735965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Fourniols T, Maggio V, Rafael D, Colaco A, García Vidal E, Lopes A, Schwartz S, Martínez-Barriocanal Á, Preat V, Arango D. Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation. Eur J Pharm Biopharm 2022:S0939-6411(21)00272-1. [PMID: 34998911 DOI: 10.1016/j.ejpb.2021.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Álvarez Lorenzo C, Lema Oreiro M, Concheiro Nine Á. Oral administration of cytostatic drugs in the treatment of CRC. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00015-6] [Reference Citation Analysis]
9 Nasery MM, Abadi B, Seyedpour N, Bazdar P, Eslaminejad T. Smart bio-encapsulation for immunotherapy. Smart Nanomaterials for Bioencapsulation 2022. [DOI: 10.1016/b978-0-323-91229-7.00009-x] [Reference Citation Analysis]
10 Mahajan NM, Chaudhari A, More S, Gangane P. Nanotherapeutics for colon cancer. Photophysics and Nanophysics in Therapeutics 2022. [DOI: 10.1016/b978-0-323-89839-3.00005-1] [Reference Citation Analysis]
11 Zoschke C, Schäfer‐korting M. Overcoming the Translational Gap – Nanotechnology in Dermal Drug Delivery. Fundamentals of Drug Delivery 2021. [DOI: 10.1002/9781119769644.ch11] [Reference Citation Analysis]
12 Ünal S, Can Öztürk S, Bilgiç E, Yanık H, Korkusuz P, Aktaş Y, Benito JM, Esendağlı G, Bilensoy E. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model. Eur J Pharm Biopharm 2021:S0939-6411(21)00265-4. [PMID: 34700001 DOI: 10.1016/j.ejpb.2021.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vodyashkin AA, Rizk MGH, Kezimana P, Kirichuk AA, Stanishevskiy YM. Application of Gold Nanoparticle-Based Materials in Cancer Therapy and Diagnostics. ChemEngineering 2021;5:69. [DOI: 10.3390/chemengineering5040069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Wang H, Tian T, Zhang J. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. Int J Mol Sci 2021;22:8470. [PMID: 34445193 DOI: 10.3390/ijms22168470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 23.0] [Reference Citation Analysis]
15 Zafar H, Raza F, Ma S, Wei Y, Zhang J, Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy. Biomater Sci 2021;9:5092-115. [PMID: 34160488 DOI: 10.1039/d1bm00721a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
16 Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Preclinical models and technologies to advance nanovaccine development. Adv Drug Deliv Rev 2021;172:148-82. [PMID: 33711401 DOI: 10.1016/j.addr.2021.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
17 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
18 Vinchhi P, Patel MM. Triumph against cancer: invading colorectal cancer with nanotechnology. Expert Opin Drug Deliv 2021;18:1169-92. [PMID: 33567909 DOI: 10.1080/17425247.2021.1889512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Wang Y, Xie H, Ying K, Xie B, Chen X, Yang B, Jin J, Wan J, Li T, Han W, Fang S, Wang H. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies. Biomaterials 2021;270:120705. [PMID: 33581609 DOI: 10.1016/j.biomaterials.2021.120705] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
20 Maspes A, Pizzetti F, Rossetti A, Makvandi P, Sitia G, Rossi F. Advances in Bio-Based Polymers for Colorectal CancerTreatment: Hydrogels and Nanoplatforms. Gels 2021;7:6. [PMID: 33440908 DOI: 10.3390/gels7010006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Carreira B, Acúrcio RC, Matos AI, Peres C, Pozzi S, Vaskovich‐koubi D, Kleiner R, Bento M, Satchi‐fainaro R, Florindo HF. Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment. Adv Therap 2021;4:2000147. [DOI: 10.1002/adtp.202000147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Saravanan M, Barabadi H, Vahidi H, Webster TJ, Medina-cruz D, Mostafavi E, Vernet-crua A, Cholula-diaz JL, Periakaruppan P. Emerging theranostic silver and gold nanobiomaterials for breast cancer: Present status and future prospects. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications 2021. [DOI: 10.1016/b978-0-12-821013-0.00004-0] [Cited by in Crossref: 14] [Article Influence: 14.0] [Reference Citation Analysis]
23 Javed R, Zia M, Naz S, Aisida SO, Ain NU, Ao Q. Role of capping agents in the application of nanoparticles in biomedicine and environmental remediation: recent trends and future prospects. J Nanobiotechnology 2020;18:172. [PMID: 33225973 DOI: 10.1186/s12951-020-00704-4] [Cited by in Crossref: 117] [Cited by in F6Publishing: 130] [Article Influence: 58.5] [Reference Citation Analysis]
24 Ali A, Mishra S, Kamaal S, Alarifi A, Afzal M, Saha KD, Ahmad M. Evaluation of catacholase mimicking activity and apoptosis in human colorectal carcinoma cell line by activating mitochondrial pathway of copper(II) complex coupled with 2-(quinolin-8-yloxy)(methyl)benzonitrile and 8-hydroxyquinoline. Bioorg Chem 2021;106:104479. [PMID: 33272712 DOI: 10.1016/j.bioorg.2020.104479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
25 Nieto C, Vega MA, Martín Del Valle EM. Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine. Nanomaterials (Basel) 2020;10:E1674. [PMID: 32859026 DOI: 10.3390/nano10091674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
26 Tang H, Li C, Zhang Y, Zheng H, Cheng Y, Zhu J, Chen X, Zhu Z, Piao JG, Li F. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis. Theranostics 2020;10:9865-87. [PMID: 32863964 DOI: 10.7150/thno.46771] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 22.5] [Reference Citation Analysis]
27 Bauleth-Ramos T, Feijão T, Gonçalves A, Shahbazi MA, Liu Z, Barrias C, Oliveira MJ, Granja P, Santos HA, Sarmento B. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles. J Control Release 2020;323:398-411. [PMID: 32320816 DOI: 10.1016/j.jconrel.2020.04.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
28 Shan X, Li S, Sun B, Chen Q, Sun J, He Z, Luo C. Ferroptosis-driven nanotherapeutics for cancer treatment. Journal of Controlled Release 2020;319:322-32. [DOI: 10.1016/j.jconrel.2020.01.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 37.5] [Reference Citation Analysis]
29 Barabadi H, Vahidi H, Damavandi Kamali K, Rashedi M, Hosseini O, Golnaraghi Ghomi AR, Saravanan M. Emerging Theranostic Silver Nanomaterials to Combat Colorectal Cancer: A Systematic Review. J Clust Sci 2020;31:311-21. [DOI: 10.1007/s10876-019-01668-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 14.3] [Reference Citation Analysis]